ArticleMikrochimica acta2026
Label-free milk biopsy using nanochannel-based biosensors for early-stage bovine mastitis screening.
Article in Mikrochimica acta, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A label-free electrochemical biosensor is presented for the detection of miRNA-223, a host immune-derived biomarker upregulated in early mastitis. The biosensor consists of porous anodic alumina (pAAO) membranes featuring high-aspect-ratio porous structure, functionalized with ssDNA probes. This nanochannel-based design increases surface area for probe immobilization and enhances sensitivity by amplifying hybridization-induced changes in ionic transport.Upon hybridization with miRNA-223 to the immobilized ssDNA probe, partial pore blockage impedes the diffusion of a redox probe added to the measuring solution. This change in diffusion is quantified via square wave voltammetry. The biosensor enables direct miRNA detection in raw milk, eliminating the need for RNA extraction or amplification.The biosensor was systematically optimized for pore diameter, probe concentration, and blocking conditions, and demonstrated consistent signal suppression in the presence of synthetic miRNA-223 across a dynamic range from 0.1 pM to 1 nM in both phosphate buffer and 0.1% raw milk. Application to milk collected from clinically classified cows showed clear discrimination between healthy and subclinical samples, with an area under the receiver operating characteristic curve of 0.96. Statistical analysis across 30 replicate sensor readings confirmed significant group-level discrimination (p = 0.016, Mann–Whitney U test). The biosensor’s high sensitivity and specificity are attributed to its diffusion-limited pore-based architecture and stable surface functionalization, which together enable selective and reproducible hybridization responses. Its demonstrated compatibility with raw milk furthers its robustness and analytical reliability under real sample conditions. The ability to detect early-stage, immune-derived miRNAs in minimally processed milk (0.1% v/v raw milk in phosphate buffer) supports the deployment of this biosensor in on-farm, real-time surveillance systems. By eliminating reliance on pathogen detection and enabling pre-symptomatic classification, this work aims to contribute to improved livestock health management, antimicrobial stewardship, and broader one-health objectives.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.